1. GSTP1 c.313A > G mutation is an independent risk factor for neutropenia hematotoxicity induced by anthracycline-/paclitaxel-based chemotherapy in breast cancer patients
   Juanzi Zeng et al, 2022, World Journal of Surgical Oncology CrossRef
2. The role of heavy metals in the development of colorectal cancer
   Yongsheng Li et al, 2023, BMC Cancer CrossRef
3. CRISPR/Cas9-mediated silencing of CD44: unveiling the role of hyaluronic acid-mediated interactions in cancer drug resistance
   Zhujun Xu, 2023, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
4. An Integrated Bioinformatics Analysis towards the Identification of Diagnostic, Prognostic, and Predictive Key Biomarkers for Urinary Bladder Cancer
   Michail Sarafidis et al, 2022, Cancers CrossRef
5. TOP2A correlates with poor prognosis and affects radioresistance of medulloblastoma
   Yufeng Zhang et al, 2022, Frontiers in Oncology CrossRef
6. Gender-dependent association ofTYMS-TSER polymorphism with 5-fluorouracil or capecitabine-based chemotherapy toxicity
   Charalampia Ioannou et al, 2021, Pharmacogenomics CrossRef
7. Research on radiotherapy related genes and prognostic target identification of rectal cancer based on multi-omics
   Yi Liu et al, 2023, Journal of Translational Medicine CrossRef
8. Transcriptome analysis of the response to low temperature acclimation in Calliptamus italicus eggs
   Qian Liu et al, 2022, BMC Genomics CrossRef
9. ERCC1 is a potential biomarker for predicting prognosis, immunotherapy, chemotherapy efficacy, and expression validation in HER2 over-expressing breast cancer
   Yilun Li et al, 2022, Frontiers in Oncology CrossRef
10. Increased LZTS1 expression is associated with a good response to paclitaxel-based chemotherapy in breast cancer
    Weidong Li et al, 2022, Pathology - Research and Practice CrossRef